Published in Neonatology on May 27, 2009
Current research on opioid receptor function. Curr Drug Targets (2012) 1.07
Effects of neonatal stress and morphine on murine hippocampal gene expression. Pediatr Res (2011) 0.91
Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis. Behav Brain Res (2011) 0.86
Postnatal morphine administration alters hippocampal development in rats. J Neurosci Res (2011) 0.85
HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation. Glia (2012) 0.84
Dose-dependent effects of morphine exposure on mRNA and microRNA (miR) expression in hippocampus of stressed neonatal mice. PLoS One (2015) 0.75
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci (2003) 3.64
The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci (2008) 3.54
Annual summary of vital statistics: 2006. Pediatrics (2008) 3.18
Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet (1993) 2.99
Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend (1998) 2.94
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther (2005) 2.66
Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci (2007) 2.51
Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics (2007) 2.43
Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics (2005) 2.32
Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet (2004) 2.10
Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate (2000) 1.85
Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA (2003) 1.66
Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J Biol Chem (2003) 1.58
Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr (1996) 1.51
Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res (1995) 1.49
The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci (2007) 1.36
Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J Neurosci (1999) 1.32
Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J Neurosci (2007) 1.31
Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics (2005) 1.29
Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo. Glia (2001) 1.05
Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol (1997) 1.01
Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sci (1992) 1.01
A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology (2007) 0.96
Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology (2005) 0.95
The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res (1987) 0.94
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain Behav Immun (2007) 0.93
Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology (2008) 0.93
Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur J Pharmacol (2000) 0.90
Analgesia for ventilated neonates: where do we stand? J Pediatr (1999) 0.86
Narcotic analgesia for ventilated newborns: are placebo-controlled trials ethical and necessary? J Pediatr (1999) 0.85
Effect of morphine sulfate on neonatal neutrophil chemotaxis. Clin J Pain (2008) 0.83
Characterization of opioid receptors in cultured neurons. J Neurochem (1990) 0.83
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients. Psychiatry Res (1990) 0.82
Kappa opioid receptor is expressed in the rat cerebellar cortex. Cell Tissue Res (2005) 0.78
Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice. Neuroimmunomodulation (2007) 0.78
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci (2003) 3.64
The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci (2008) 3.54
Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. J Neurosci (2009) 2.78
Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci (2007) 2.51
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev (2013) 2.42
Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature (2012) 2.19
Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol Pharmacol (2004) 2.00
Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem (2006) 1.97
Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem (2007) 1.91
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) (2010) 1.90
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A (2009) 1.88
Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron (2011) 1.83
Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology (2006) 1.81
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) (2008) 1.68
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A (2010) 1.63
Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology (2006) 1.60
Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J Biol Chem (2003) 1.58
CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One (2009) 1.48
A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics (2008) 1.46
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem (2003) 1.45
Characterization of individual mouse cerebrospinal fluid proteomes. Proteomics (2014) 1.44
Conservation of the phosphate-sensitive elements in the arrestin family of proteins. J Biol Chem (2002) 1.42
A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res (2007) 1.39
Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J Neurosci (2007) 1.31
Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res (2007) 1.30
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics (2012) 1.29
Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci (2004) 1.26
G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol (2003) 1.23
Duration of action of a broad range of selective κ-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol Pharmacol (2011) 1.20
Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci (2012) 1.18
Opioid systems in the dentate gyrus. Prog Brain Res (2007) 1.17
Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport (2008) 1.17
Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. Br J Pharmacol (2004) 1.16
Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr (2009) 1.14
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci (2013) 1.13
Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res (2005) 1.10
Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions. J Pain (2008) 1.08
Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J Neurosci (2008) 1.08
Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev Neurosci (2007) 1.08
Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr (2010) 1.08
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr (2012) 1.07
Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate (2003) 1.07
Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms. Neuropsychopharmacology (2010) 1.07
Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr Res (2009) 1.06
Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J Biol Chem (2006) 1.06
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci (2012) 1.04
mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J Biol Chem (2002) 0.99
N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. J Biol Chem (2002) 0.98
Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. Mol Pharmacol (2006) 0.97
Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci (2007) 0.97
Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A (2011) 0.97
A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology (2007) 0.96
The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int (2012) 0.96
Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation. Neuron (2013) 0.95
Prenatal cord clamping in newborn Macaca nemestrina: a model of perinatal asphyxia. Dev Neurosci (2007) 0.94
Alpha-dystrobrevin-1 recruits alpha-catulin to the alpha1D-adrenergic receptor/dystrophin-associated protein complex signalosome. Proc Natl Acad Sci U S A (2010) 0.93
Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology (2008) 0.93
Rising prevalence of gastroschisis in Washington State. J Toxicol Environ Health A (2011) 0.92
Tyrosine phosphorylation of K(ir)3.1 in spinal cord is induced by acute inflammation, chronic neuropathic pain, and behavioral stress. J Biol Chem (2005) 0.91
Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy. Mol Pharmacol (2009) 0.91
Postnatal stress produces hyperglycemia in adult rats exposed to hypoxia-ischemia. Pediatr Res (2009) 0.91
Effects of neonatal stress and morphine on murine hippocampal gene expression. Pediatr Res (2011) 0.91
Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr (2006) 0.90
Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice. Mol Pain (2010) 0.89
Left ventricular hypertrophy is prevalent in Sprague-Dawley rats. Comp Med (2010) 0.89
Binge alcohol exposure in the second trimester attenuates fetal cerebral blood flow response to hypoxia. J Appl Physiol (1985) (2007) 0.89
Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology (2006) 0.89
Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism. J Neurosci (2012) 0.88
Ligand directed signaling differences between rodent and human κ-opioid receptors. J Biol Chem (2012) 0.88
Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus. J Comp Neurol (2009) 0.88
Effects of first trimester binge alcohol exposure on developing white matter in fetal sheep. Pediatr Res (2006) 0.87
Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis. Behav Brain Res (2011) 0.86
High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatr Res (2009) 0.86
Fetal alcohol exposure alters cerebrovascular reactivity to vasoactive intestinal peptide in adult sheep. Neonatology (2007) 0.86
Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization. J Biol Chem (2009) 0.86
High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine. Growth Horm IGF Res (2007) 0.86
Perinatal asphyxia in a nonhuman primate model. Dev Neurosci (2011) 0.85
Evaluation of neutropenia and neutrophilia in hospitalized preterm infants. J Perinatol (2004) 0.84
Evaluation of eosinophilia in hospitalized preterm infants. J Perinatol (2005) 0.82
The perinatal transition of the circulating metabolome in a nonhuman primate. Pediatr Res (2012) 0.82
Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats. J Pain (2007) 0.81
Agonist-induced internalization of κ-opioid receptors in noradrenergic neurons of the rat locus coeruleus. J Chem Neuroanat (2010) 0.81
Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury. J Neurotrauma (2014) 0.80